Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3221 Independent administration of long-acting somatostatin analogues (SSAs) for the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NET): Potential savings of increased uptake in the UK National Health Service (NHS)

Introduction: Lanreotide Autogel (LAN) and octreotide long-acting release (OCT) are long-acting SSAs used to treat GEP-NET. Only LAN is approved for independent (self/partner) injection, obviating need for in-person provider visits. Uptake of this option, already convenient for some patients, has accelerated in the UK amid the COVID-19 pandemic, with delivery modes reorganized in line with “COVID-19 rapid guideline: delivery of systemic anticancer treatments [NG161]” published for the NHS.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Harrow B, Cristeau O, Clay E, Francois C, Frankcom I,

Keywords: somatostatin analogues, GEP-NET, HEOR, covid-19,